Regulatory Compliance at the Forefront of Patient Safety

Qualified Pharmacovigilance Partner of Choice

Industry-leading experience and innovation

UBC, a leader in pharmacovigilance, combines deep clinical expertise with innovative technologies to enable biopharmaceutical industries to comply with global and local pharmacovigilance regulations across the product lifecycle, from initial clinical development to post-marketing surveillance.

Led by a team of pharmacovigilance experts, we have a deep understanding of the complex and rapidly evolving safety landscape and regulations. We are supported by an unmatched technology suite and operate on the principle that patient safety is a critical industry responsibility.

0 +
30 regulatory inspections, with no critical findings
0 %
70% of our clients outsource to us in a full-service capacity

* From 2018 to Q2 2023

Pharmacovigilance Difference

Full-Service Outsourcing

Pharmacovigilance is vital for drug development and establishment of a product’s benefit-risk profile, and choosing the right partner is critical for success. UBC enables our customers to identify and manage potential risks associated with their products, maintain patient safety, and ensure high regulatory compliance throughout the drug development and commercialization process.

Pharmacovigilance Services

58,000 cases processed annually
0 %
99% on-time regulatory submission compliance

Learn More About UBC's Pharmacovigilance Services

Interested in learning more about how UBC’s pharmacovigilance services can help you make more informed decisions earlier and meet regulatory requirements?

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.